Acquiring Company
BioCryst Pharmaceuticals
Acquired Company
Astria Therapeutics
DurhamBostonBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareTherapeuticsBiopharmaDescription
BioCryst Pharmaceuticals has completed its acquisition of Astria Therapeutics to enhance its portfolio by gaining access to navenibart, a drug for hereditary angioedema. This move is part of BioCryst's strategy to expand into rare-disease treatments. The acquisition reportedly cost around $700 million. BioCryst is positioning itself as a significant player in the rare-disease market.
Don't miss BioCryst Pharmaceuticals's next move
Get an email the moment BioCryst Pharmaceuticals makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Astria Therapeutics?
Astria Therapeutics was acquired by BioCryst Pharmaceuticals, based in Durham. The deal was reported on August 29, 2026. BioCryst is focused on developing novel therapies for diseases with significant unmet needs. BioCryst Pharmaceuticals is publicly traded (BCRX) and operates in Biotechnology.
When did BioCryst Pharmaceuticals acquire Astria Therapeutics?
BioCryst Pharmaceuticals's acquisition of Astria Therapeutics was reported on August 29, 2026. BioCryst Pharmaceuticals has completed its acquisition of Astria Therapeutics to enhance its portfolio by gaining access to navenibart, a drug for hereditary angioedema. This move is part of BioCryst's strategy to expand into rare-disease treatments. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Astria Therapeutics do?
Astria Therapeutics is a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.